Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors

NCT01428427 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukaemia, Myelocytic, Acute

Interventions

DRUG: GSK1120212
DRUG: Gemcitabine

Sponsor

GlaxoSmithKline